Summary & Overview
HCPCS J1370: Injection of Esomeprazole Sodium, 1 mg
HCPCS Level II code J1370 designates the injection of esomeprazole sodium, 1 mg. As a code for parenteral administration of a proton pump inhibitor, it is used across hospital, outpatient, and office-based infusion settings to bill for the drug component when esomeprazole is delivered by injection. Nationally, drug administration codes like J1370 matter because they affect drug spend reporting, reimbursement for infused therapies, and coding consistency for pharmaceutical utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for injectable esomeprazole, typical sites of service, and what the code represents in billing workflows. The publication also summarizes common payer coverage themes, typical billing modifiers used with injectable drug codes, and where J1370 fits among related drug administration codes.
This overview helps billing professionals, revenue cycle leaders, and policy analysts understand the role of J1370 in coding and claims workflows, and directs readers to benchmarks and policy updates relevant to injectable proton pump inhibitor billing. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1370 represents the injection of esomeprazole sodium, 1 mg. This code describes a pharmaceutical administration service for the proton pump inhibitor esomeprazole in a parenteral form.
-
Service type: Drug administration (parenteral injection)
-
Typical site of service: Hospital inpatient, hospital outpatient, physician office, or ambulatory infusion setting where injectable medications are provided
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult requiring intravenous or intramuscular administration of a proton pump inhibitor for acute management of gastroesophageal reflux disease (GERD), peptic ulcer disease with active bleeding, stress-related mucosal disease prophylaxis in critically ill patients, or as part of pre-procedural therapy when oral administration is not feasible. Example scenario: a 62-year-old hospitalized patient with upper gastrointestinal bleeding secondary to a bleeding duodenal ulcer who is NPO and unable to tolerate oral medications. The clinical workflow includes order entry by the attending physician, pharmacy preparation of J1370 as an injectable esomeprazole sodium dose (documented per mg), bedside verification and administration by a licensed nurse, monitoring for therapeutic response and adverse effects, and documentation of lot number, dose in mg, route, site, and reason for parenteral administration in the medical record. Billing is submitted using HCPCS Level II code J1370 with any applicable modifier(s) to describe technical circumstances or payment adjustments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard billing indicator | Use when no special billing circumstance applies |